PATH | VRL
Menu

Challenges in Developing a Pediatric RSV Vaccine

There is currently no approved respiratory syncytial virus (RSV) vaccine, and the goal of preventing RSV-associated illness in the general population remains unmet. The authors of this article, published in Human Vaccines, discuss the challenges associated with developing a pediatric RSV vaccine and review the potential pediatric RSV vaccine candidates currently under development.

Author: Schickli JH, Dubovsky F, Tang RS

Published: 2009

» Download file (English)

628 KB PDF (Located at www.landesbioscience.com)

Citation: Schickli JH, Dubovsky F, Tang RS. Challenges in Developing a Pediatric RSV Vaccine. Human Vaccines. 2009;5(9):582-591.

Resource types: Peer-reviewed journal

Diseases/vaccines: Respiratory syncytial virus (RSV)

Topics: Disease/vaccine specific information

Regions: Global